Oral live attenuated human rotavirus vaccine (Rotarix) offers sustained high protection against severe G9P[8] rotavirus gastroenteritis during the first two years of life in Brazilian children

Nav

General Info

Geography

Brazil (BRA)

Time period covered

01/2003 - 12/2005

Data type

Scientific literature

Keywords

Diarrhea, Diarrheal diseases, Rotavirus

Citation

Authors

Justino MC, Araújo EC, van Doorn LJ, Oliveira CS, Gabbay YB, Mascarenhas JD, Miranda YS, Guerra Sde F, Silva VB, Linhares AC

Journal

Mem Inst Oswaldo Cruz

Volume

107

Issue

Pages

846-53

Publication year

2012

Suggested citation

Justino MC, Araújo EC, van Doorn LJ, Oliveira CS, Gabbay YB, Mascarenhas JD, Miranda YS, Guerra Sde F, Silva VB, Linhares AC. Oral live attenuated human rotavirus vaccine (Rotarix) offers sustained high protection against severe G9P[8] rotavirus gastroenteritis during the first two years of life in Brazilian children. Mem Inst Oswaldo Cruz. 2012; 107(7): 846-53.

DOI

10.1590/s0074-02762012000700002

PMID

23147138

GHDx Entry last modified on: May 30, 2020

Header sites

Search form

Main menu

Oral live attenuated human rotavirus vaccine (Rotarix) offers sustained high protection against severe G9P[8] rotavirus gastroenteritis during the first two years of life in Brazilian children

Nav